À Propos de l'Entreprise
- Raison sociale: Chengdu Yacht Bio-technology Co., Ltd
- Pays d'enregistrement: China
- Adresse: No.7 Mansion, Tianfu Life Science Park, South Keyu, Chengdu • Sichuan
- Nombre d'employés: 100 - 249
- Année de création: 2004
Description:
Chengdu Yacht Bio-technology is engaged in the R&D, production and sales of APIs, biological drugs and intermediates across therapeutic fields including anti-tumor, anti-infective and immune system treatments. Its subsidiary, Sichuan Novals Pharmaceuticals, upholds a quality-and-service-first principle to provide high-quality products and solutions, with main products including daptomycin, micafungin, caspofungin, everolimus, dalbavancin and anidulafungin.
Activités Commerciales
Ingrédients Biologiques & de Fermentation
Fabricant
Principes Actifs Pharmaceutiques (API)
Fabricant de Principes Actifs (API)
API de Référence (Princeps)
Fabricant de Principes Actifs (API)
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Dalbavancin, Bio-synthesis and semi-synthesis APIs
- Formes Pharmaceutiques Finies: Finished dosage forms
- Produits Chimiques Pharmaceutiques: Caspofungin Acetate, Micafungin sodium, DALBAVANCIN HYDROCHLORIDE
- API de Référence (Princeps): Caspofungin Acetate, Everolimus, Micafungin sodium, Dalbavancin
Nos Produits & Services
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire